Beta Bionics (BBNX) Competitors $14.12 -0.18 (-1.26%) As of 01:22 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BBNX vs. LIVN, WRBY, PRCT, INSP, LMAT, EYE, LQDA, CNMD, ENOV, and AORTShould you be buying Beta Bionics stock or one of its competitors? The main competitors of Beta Bionics include LivaNova (LIVN), Warby Parker (WRBY), PROCEPT BioRobotics (PRCT), Inspire Medical Systems (INSP), LeMaitre Vascular (LMAT), National Vision (EYE), Liquidia Technologies (LQDA), CONMED (CNMD), Enovis (ENOV), and Artivion (AORT). These companies are all part of the "medical equipment" industry. Beta Bionics vs. Its Competitors LivaNova Warby Parker PROCEPT BioRobotics Inspire Medical Systems LeMaitre Vascular National Vision Liquidia Technologies CONMED Enovis Artivion LivaNova (NASDAQ:LIVN) and Beta Bionics (NASDAQ:BBNX) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment. Do analysts prefer LIVN or BBNX? LivaNova currently has a consensus target price of $59.29, indicating a potential upside of 16.57%. Beta Bionics has a consensus target price of $22.56, indicating a potential upside of 60.08%. Given Beta Bionics' higher probable upside, analysts clearly believe Beta Bionics is more favorable than LivaNova.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LivaNova 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00Beta Bionics 0 Sell rating(s) 4 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.75 Does the media favor LIVN or BBNX? In the previous week, LivaNova had 20 more articles in the media than Beta Bionics. MarketBeat recorded 21 mentions for LivaNova and 1 mentions for Beta Bionics. Beta Bionics' average media sentiment score of 1.72 beat LivaNova's score of 0.70 indicating that Beta Bionics is being referred to more favorably in the news media. Company Overall Sentiment LivaNova Positive Beta Bionics Very Positive Is LIVN or BBNX more profitable? Beta Bionics has a net margin of 0.00% compared to LivaNova's net margin of -16.13%. LivaNova's return on equity of 14.57% beat Beta Bionics' return on equity.Company Net Margins Return on Equity Return on Assets LivaNova-16.13% 14.57% 6.91% Beta Bionics N/A N/A N/A Do institutionals and insiders believe in LIVN or BBNX? 97.6% of LivaNova shares are owned by institutional investors. 0.3% of LivaNova shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has preferable earnings & valuation, LIVN or BBNX? LivaNova has higher revenue and earnings than Beta Bionics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLivaNova$1.25B2.22$63.23M-$3.89-13.07Beta Bionics$65.12M9.41-$54.76MN/AN/A SummaryLivaNova beats Beta Bionics on 8 of the 13 factors compared between the two stocks. Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BBNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBNX vs. The Competition Export to ExcelMetricBeta BionicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$612.49M$6.80B$5.50B$9.79BDividend YieldN/A1.33%4.59%4.13%P/E RatioN/A25.1129.9825.07Price / Sales9.4167.32449.59102.38Price / CashN/A21.3524.8128.01Price / Book-2.464.838.665.82Net Income-$54.76M$176.29M$3.26B$265.14M7 Day Performance-10.88%0.12%0.57%0.67%1 Month Performance11.21%-1.97%3.12%1.83%1 Year PerformanceN/A11.90%45.56%27.21% Beta Bionics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBNXBeta BionicsN/A$14.12-1.3%$22.56+59.7%N/A$613.80M$65.12M0.00294LIVNLivaNova2.2504 of 5 stars$48.52+2.4%$59.29+22.2%+12.8%$2.58B$1.25B-12.472,900Earnings ReportAnalyst UpgradeWRBYWarby Parker2.032 of 5 stars$23.48-3.4%$23.81+1.4%+76.6%$2.54B$771.32M-195.633,780High Trading VolumePRCTPROCEPT BioRobotics3.4204 of 5 stars$39.59-13.4%$74.88+89.1%-36.6%$2.53B$274.95M-25.54430Trending NewsEarnings ReportAnalyst UpgradeAnalyst RevisionGap DownHigh Trading VolumeINSPInspire Medical Systems4.6505 of 5 stars$77.20-1.6%$173.31+124.5%-58.8%$2.32B$802.80M44.621,246Buyback AnnouncementLMATLeMaitre Vascular2.4 of 5 stars$94.26+1.1%$98.00+4.0%+10.6%$2.11B$234.64M45.76490Earnings ReportHigh Trading VolumeEYENational Vision3.0267 of 5 stars$24.17+1.2%$24.73+2.3%+121.5%$1.89B$1.82B-134.2813,411Positive NewsEarnings ReportAnalyst UpgradeLQDALiquidia Technologies3.2088 of 5 stars$19.21-5.4%$26.89+40.0%+82.0%$1.74B$14M-12.1650News CoverageEarnings ReportOptions VolumeGap UpCNMDCONMED4.4538 of 5 stars$53.34+4.5%$59.80+12.1%-21.7%$1.58B$1.31B15.113,900Dividend AnnouncementHigh Trading VolumeENOVEnovis3.8253 of 5 stars$28.45+10.4%$57.00+100.4%-35.1%$1.47B$2.11B-2.047,367Earnings ReportAnalyst RevisionAORTArtivion3.1917 of 5 stars$32.78+1.6%$32.40-1.2%+73.3%$1.38B$388.54M-65.571,600News CoverageEarnings ReportAnalyst Upgrade Related Companies and Tools Related Companies LivaNova Competitors Warby Parker Competitors PROCEPT BioRobotics Competitors Inspire Medical Systems Competitors LeMaitre Vascular Competitors National Vision Competitors Liquidia Technologies Competitors CONMED Competitors Enovis Competitors Artivion Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BBNX) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access